Walmart to replace Astrazeneca on Nasdaq-100 Jan 9 (Reuters) - Nasdaq NDAQ.O on Friday said U.S. retailer Walmart WMT.O will replace British drugmaker Astrazeneca AZN.L in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)
((RheaRose.Abraham@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments